Knowledge Center · Peptides

Kisspeptin-10

Reproductive signaling

The upstream switch for the entire reproductive hormone axis — the signal that tells the brain to start the cascade.

What it is

Kisspeptin sits at the top of the reproductive hormone hierarchy. It is the signal that tells the hypothalamus to release GnRH, which tells the pituitary to release LH and FSH, which tells the gonads to produce testosterone or estrogen. Its discovery reorganized the field's understanding of how puberty and fertility are controlled — people lacking functional kisspeptin signaling do not go through puberty at all.

What people use it for

• Investigating and supporting the hormonal axis at its origin rather than downstream
• Fertility research, where most of the serious human work sits
• Interest in preserving natural signaling rather than replacing hormones
• Sexual desire and arousal, a more recent and interesting line of research

How it works

Rather than adding testosterone from outside, kisspeptin pushes the button at the top of your own system and lets the cascade run normally. That is a genuinely different approach, and the appeal is obvious — the natural signal keeps its natural rhythm and feedback. The complication is that biology has feedback loops precisely to prevent things from being pushed indefinitely.

What to realistically expect

The acute hormonal response is measurable and reasonably reliable in research settings. Whether repeated administration produces durable benefit is exactly what has not been established, and receptor desensitization with continuous exposure is a documented phenomenon with this system.

What it will not do

Every page on this site includes this section. If a source only tells you what something does, you are reading marketing.

• It will not replace testosterone therapy in someone with primary gonadal failure — if the gonads cannot respond, signaling them harder achieves nothing.
• It will not restore an axis suppressed by anabolic steroid use, which is a specific clinical problem with its own approach.
• It will not overcome the suppression caused by energy deficit, overtraining, or poor sleep — those are inputs to the same system.
• It has no evidence for sustained hormone optimization, which is the primary way it is marketed.

Safety and who should be cautious

Human research administration has been well tolerated, though studies have generally been short. Not FDA- or EMA-approved. Because it acts on the reproductive axis, it is inappropriate for anyone with a hormone-sensitive cancer without oncology input, and anyone trying to conceive should have this conversation with a fertility specialist rather than improvising. Not appropriate during pregnancy.

Sourcing and quality

Third-party purity testing with a batch-matched certificate of analysis. Given that the intended effects are hormonal and invisible without labs, verification matters more here than with a compound you can feel.

Questions worth asking your provider

• Have we measured LH, FSH, and total and free testosterone to know where the problem actually is?
• Is my axis suppressed for a reason we should address — sleep, energy availability, prior steroid use?
• If fertility is the goal, should I be seeing a reproductive endocrinologist instead?

Frequently asked questions

Is kisspeptin better than TRT?

They solve different problems. Kisspeptin signals a working axis; testosterone replacement substitutes for one that is not producing. If the gonads cannot respond, kisspeptin has nothing to act on.

Is there human evidence?

Good physiological evidence that it raises LH and testosterone acutely, plus interesting neuroimaging work. No evidence for sustained therapeutic use.

Will it restore function after steroid use?

That is not established. Post-cycle axis recovery is a specific clinical situation that deserves a knowledgeable provider.

Related

Pt 141Sermorelin